MedStar Georgetown University Hospital — Washington D.C., District of Columbia

MedStar Georgetown University Hospital is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

MedStar Georgetown University Hospital has participated in 393 clinical trials with 200 currently active.

Therapeutic areas: Triple Negative Breast Cancer, Astrocytoma, IDH-Mutant, Grade 2, Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant.

Sponsors: Georgetown University, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MedStar Georgetown University Hospital?

MedStar Georgetown University Hospital has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MedStar Georgetown University Hospital conducted?

MedStar Georgetown University Hospital has 393 clinical trials on record, with 200 currently active. Their work covers Triple Negative Breast Cancer, Astrocytoma, IDH-Mutant, Grade 2, Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant.

Is MedStar Georgetown University Hospital accredited by Crixeo Health?

MedStar Georgetown University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MedStar Georgetown University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.